Pricing Log in Create free account

Psyence Biomedical Ltd. (PBM) vs Vaxxinity, Inc. (VAXX)

Psyence Biomedical Ltd. and Vaxxinity, Inc. are both Biotechnology companies. Psyence Biomedical Ltd. and Vaxxinity, Inc. are of similar size ($16.5M and $15.5M). Vaxxinity, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 9 metrics below, Psyence Biomedical Ltd. leads on 5 and Vaxxinity, Inc. on 4.

Valuation

Metric PBM VAXX Biotechnology median
P/E 0.19 n/m 8.50
P/S n/m n/m 9.71
P/B 0.08 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.82 0.30 0.64
EV/Sales n/m (94.20) 9.21
Earnings yield 534.77% 0.00% (33.15%)
Free cash flow yield (807.70%) 0.00% (25.50%)

Profitability

Metric PBM VAXX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (23.52%) (150.65%) (56.36%)
Return on assets (6.74%) (75.55%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PBM VAXX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (138.35%) 25.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PBM VAXX Biotechnology median
Debt to equity 0.00 0.99 0.00
Current ratio 8.09 1.89 4.72
Net debt to EBITDA 1.20 0.30 0.96

Dividend

Metric PBM VAXX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PBM VAXX Biotechnology median
Market cap 16.47m 15.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack